Fluorescence image-guided lymphadenectomy using indocyanine green and near infrared technology in robotic gastrectomy
Brief Communication

Fluorescence image-guided lymphadenectomy using indocyanine green and near infrared technology in robotic gastrectomy

Jacopo Desiderio1,2, Stefano Trastulli1, Alessandro Gemini1, Domenico Di Nardo2, Giorgio Palazzini2, Amilcare Parisi1, Vito D’Andrea2

1Department of Digestive Surgery, St. Mary’s Hospital, Terni 05100, Italy; 2Department of Surgical Sciences, “La Sapienza” University of Rome, Rome 00161, Italy

Correspondence to: Jacopo Desiderio, MD. Department of Digestive Surgery, St. Mary’s Hospital, Terni 05100, Italy; Department of Surgical Sciences, "La Sapienza" University of Rome, Rome 00161, Italy. Email: j.desiderio@aospterni.it; djdesi85@hotmail.it.

Abstract

In recent years, some researchers have tried to find a way to improve the surgical identification of the lymphatic drainage routes and lymph node stations during radical gastrectomy, thus starting a new research frontier in this field called " navigation surgery”. Among the different reported solutions, the introduction of the indocyanine green (ICG) has drawn attention for its characteristics, a fluorescence dye that can be detected in the near infrared spectral band (NIR). A fluorescence imaging technology has been integrated in the latest version of the Da Vinci robotic system and surgeons have extensively reported their experiences in colorectal and hepato-biliary surgery for tumors, vascular and lymphatic structures visualization. However, up to date, the combined use of fluorescence imaging and robotic technology has not been adequately investigated during lymphadenectomy in gastric cancer.

Keywords: Gastric cancer; fluorescence guided surgery; robotic surgery

Submitted Sep 02, 2018. Accepted for publication Oct 09, 2018.

doi: 10.21147/j.issn.1000-9604.2018.05.11

Gastric cancer is the fourth most widespread cancer in the world, characterized by high mortality rates (1,2) and needs a specialized management in the context of a dedicated multidisciplinary team.

Surgery is crucial in the patient’s therapeutic path and lymphadenectomy must guarantee not only the oncological radicality, but even an appropriate tumor staging. The two latest editions of the Japanese Gastric Cancer Association (JGCA) guidelines (3) have tried to standardize this procedure recommending a dissection on different levels (D1, D1+, D2), based on the type of gastrectomy and the clinical stage of the tumor.

Lymph node involvement in gastric cancer account for 2%−18% when the depth of the tumor invasion is limited to the mucosal or submucosal layer but rises to 50% when the tumor involves the subserosa, and thus lymphadenectomy is considered the most relevant factor influencing long-term survival even if still under debate (4).

In recent years, some researchers have tried to apply the concept of “sentinel lymph node” to gastric cancer (5-7) with the aim to develop a different lymphadenectomy concept.

Although some authors do not consider that terminology the appropriate one in the context of gastric cancer, because of the multidirectional gastric lymphatic flows, several studies have highlighted interesting aspects, such as: trying to limit an extensive lymphatic dissection when not necessary, identifying the drainage routes outside the standard anatomical planes, and possible assistance in minimally invasive procedures (8).

Most of the experiences in lymph nodes mapping were performed with a radio-isotope (Tc99m) associated or not with the intraoperative use of vital dyes (Blue dye), but more recently, the properties of the indocyanine green (ICG), a fluorescence dye that can be detected in the near infrared spectral band, have been studied (9,10).

The development of imaging tools using infrared spectral band (NIR)/ICG technology is therefore an innovative approach for visualizing tumors, vascular structures, lymphatic channels and lymph nodes (11).

Some advantages of the ICG are: reduced toxicity, absence of radioactivity, low cost, safe administration both intravenous and endoscopical through the submucosa or subserosa, protein binding without changing molecular structures, and macrophages interaction at the lymph node level.

Devices for fluorescence imaging are currently available in both open and minimally invasive surgery and in the latter, robotic surgery has been becoming of great interest thanks to the manufacturing of new instruments which, compared to laparoscopy, allow to improve manual skills and gentleness in challenging movements (12).

The Da Vinci Xi robotic system has produced an innovative imaging technology for ICG visualization made up with a laser source integrated in the robotic camera (Firefly).

Therefore, the surgeon at the console has a 3-D vision that can switch to the fluorescence mode without the need to change the camera. Few clinical experiences have been reported to date (12) and with the most published articles that discuss its use in colorectal and hepato-biliary surgery for vessels or biliary structures visualization, while its adoption during lymph node dissection for gastric cancer has not yet been the subject of study protocols.

Fluorescence imaging during lymphadenectomy in gastric cancer can significantly improve the quality of the dissection through a better visualization of anatomical planes allowing tailored dissections. Moreover, the tumor status in the fluorescent nodes could predict the nodes status in the overall specimen with high accuracy rate.

Thus, new research projects in this field should verify the feasibility and the role of a lymphadenectomy assisted by fluorescence imaging during robotic gastrectomy through two levels of investigation: 1) detecting the possible advantages of a fluorescence-guided surgery (“Navigation Surgery”); and 2) evaluating the possibility of considering the lymph nodes labeled by the ICG as a predictive factor of the state of tumor diffusion (“Targeted Surgery”).

Acknowledgements

None.

Footnote

Conflicts of Interest: The authors have no conflicts of interest to declare.

References

  1. Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012;13:790–801. [PubMed] DOI:10.1016/S1470-2045(12)70211-5
  2. Hartgrink HH, Jansen EP, van Grieken NC, et al. Gastric cancer. Lancet 2009;374:477–90. [PubMed] DOI:10.1016/S0140-6736(09)60617-6
  3. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20:1–19. [PubMed] DOI:10.1007/s10120-016-0622-4
  4. Sasako M, McCulloch P, Kinoshita T, et al. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995;82:346–51. [PubMed] DOI:10.1002/bjs.1800820321
  5. Kitagawa Y, Fujii H, Mukai M, et al. Radio-guided sentinel node detection for gastric cancer. Br J Surg 2002;89:604–8. [PubMed] DOI:10.1046/j.1365-2168.2002.02065.x
  6. Kitagawa Y, Takeuchi H, Takagi Y, et al. Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol 2013;31:3704–10. [PubMed] DOI:10.1200/JCO.2013.50.3789
  7. Kitagawa Y, Fujii H, Kumai K, et al. Recent advances in sentinel node navigation for gastric cancer: a paradigm shift of surgical management. J Surg Oncol 2005;90:147–51;discussion 151-2. [PubMed] DOI:10.1002/jso.20220
  8. Tani T, Sonoda H, Tani M. Sentinel lymph node navigation surgery for gastric cancer: Does it really benefit the patient? World J Gastroenterol 2016;22:2894–9. [PubMed] DOI:10.3748/wjg.v22.i10.2894
  9. Vahrmeijer AL, Hutteman M, van der Vorst JR, et al. Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol 2013;10:507–18. [PubMed] DOI:10.1038/nrclinonc.2013.123
  10. Yoshida M, Kubota K, Kuroda J, et al. Indocyanine green injection for detecting sentinel nodes using color fluorescence camera in the laparoscopy-assisted gastrectomy. J Gastroenterol Hepatol 2012;27 Suppl 3:29–33. [PubMed] DOI:10.1111/j.1440-1746.2012.07067.x
  11. Bu L, Shen B, Cheng Z. Fluorescent imaging of cancerous tissues for targeted surgery. Adv Drug Deliv Rev 2014;76:21–38. [PubMed] DOI:10.1016/j.addr.2014.07.008
  12. Marano A, Priora F, Lenti LM, et al. Application of fluorescence in robotic general surgery: review of the literature and state of the art. World J Surg 2013;37:2800–11. [PubMed] DOI:10.1007/s00268-013-2066-x
    13. Cite this article as: Desiderio J, Trastulli S, Gemini A, Di Nardo D, Palazzini G, Parisi A, D’Andrea V. Fluorescence image-guided lymphadenectomy using indocyanine green and near infrared technology in robotic gastrectomy. Chin J Cancer Res 2018;30(5):568-570. doi: 10.21147/j.issn.1000-9604.2018.05.11